
Pomdoctor fell 97.9% from $77.22 to $1.61, behind the S&P 500's +10.2%. Its worst day was Dec 10 (−90.8%), and its low came Oct 19 at $0.53.
Nov 19, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-28.80 was reported on $24.4M revenue.
−3.5% · S&P 500 +0.1%
Pomdoctor shares rose 83.3%, while the S&P 500 rose 0.9%.
+83.3% · S&P 500 +0.9%
Story events cover the past 12 months · Times ET
EPS of $-56.52 was reported on $57.2M revenue.
−6.6% · S&P 500 −1.2%
Pomdoctor closed at its lowest level of the year, 99.3% below where the year started.
−15.9% · S&P 500 +0.4%
Where it ended: a close of $1.61 on Nov 18, 2026. Up next: H1 2026 earnings on Dec 1, 2026.
Nothing in the past 12 months.
All POM analyst actionsNothing in the past 12 months.
All POM dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for POM and SPY from Benzinga historical bars. Not investment advice.